Literature DB >> 10905379

Diagnosis and management of adult growth hormone deficiency.

K K Ho1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10905379     DOI： 10.1385/ENDO:12:2:189

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.925


× No keyword cloud information.
  79 in total

Review 1.  Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

2.  Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.

Authors:  S E Hankinson; W C Willett; G A Colditz; D J Hunter; D S Michaud; B Deroo; B Rosner; F E Speizer; M Pollak
Journal:  Lancet       Date:  1998-05-09       Impact factor: 79.321

3.  The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system.

Authors:  K Y Ho; A J Weissberger
Journal:  Metabolism       Date:  1990-02       Impact factor: 8.694

4.  Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden.

Authors:  C Bengtsson; C Björkelund; L Lapidus; L Lissner
Journal:  BMJ       Date:  1993-11-27

5.  Long-term growth hormone treatment in growth hormone deficient adults.

Authors:  J O Jørgensen; S A Pedersen; L Thuesen; J Jørgensen; J Møller; J Müller; N E Skakkebaek; J S Christiansen
Journal:  Acta Endocrinol (Copenh)       Date:  1991-11

6.  Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center study.

Authors:  H B Baum; B M Biller; L Katznelson; D S Oppenheim; D R Clemmons; K B Cannistraro; D A Schoenfeld; S A Best; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

7.  Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial.

Authors:  P Burman; J E Broman; J Hetta; I Wiklund; E M Erfurth; E Hagg; F A Karlsson
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

8.  Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Authors:  W M Drake; D Coyte; C Camacho-Hübner; N M Jivanji; G Kaltsas; D F Wood; P J Trainer; A B Grossman; G M Besser; J P Monson
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

9.  Premature mortality due to cardiovascular disease in hypopituitarism.

Authors:  T Rosén; B A Bengtsson
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

10.  New approach to the diagnosis of growth hormone deficiency in adults.

Authors:  E Ghigo; G Aimaretti; L Gianotti; J Bellone; E Arvat; F Camanni
Journal:  Eur J Endocrinol       Date:  1996-03       Impact factor: 6.664
View more
  2 in total

Review 1.  Hormones as doping in sports.

Authors:  Leonidas H Duntas; Vera Popovic
Journal:  Endocrine       Date:  2012-09-19       Impact factor: 3.633

2.  Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study.

Authors:  Chris G Yedinak; Maria Fleseriu
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.